Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Oct 2023
Historique:
received: 13 09 2023
revised: 15 10 2023
accepted: 17 10 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

ANCA-associated vasculitides (AAV) are rare autoimmune diseases causing inflammation and damage to small blood vessels. New autoantibody biomarkers are needed to improve the diagnosis and treatment of AAV patients. In this study, we aimed to profile the autoantibody repertoire of AAV patients using in-house developed antigen arrays to identify previously unreported antibodies linked to the disease per se, clinical subgroups, or clinical activity. A total of 1743 protein fragments representing 1561 unique proteins were screened in 229 serum samples collected from 137 AAV patients at presentation, remission, and relapse. Additionally, serum samples from healthy individuals and patients with other type of vasculitis and autoimmune-inflammatory conditions were included to evaluate the specificity of the autoantibodies identified in AAV. Autoreactivity against members of the kinesin protein family were identified in AAV patients, healthy volunteers, and disease controls. Anti-KIF4A antibodies were significantly more prevalent in AAV. We also observed possible associations between anti-kinesin antibodies and clinically relevant features within AAV patients. Further verification studies will be needed to confirm these findings.

Identifiants

pubmed: 37895021
pii: ijms242015341
doi: 10.3390/ijms242015341
pmc: PMC10607136
pii:
doi:

Substances chimiques

Autoantibodies 0
Kinesins EC 3.6.4.4
Biomarkers 0
Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Marie Curie
ID : 813545
Pays : United Kingdom

Références

Cell Rep. 2022 May 31;39(9):110873
pubmed: 35649350
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
J Med Genet. 2020 Dec;57(12):797-807
pubmed: 32430361
J Clin Rheumatol. 2019 Aug;25(5):217-223
pubmed: 30896460
J Am Soc Nephrol. 2012 Mar;23(3):556-66
pubmed: 22323643
Autoimmun Rev. 2023 Jun;22(6):103328
pubmed: 36990133
Autoimmun Rev. 2013 Feb;12(4):477-82
pubmed: 22921791
Front Med (Lausanne). 2022 Jul 04;9:844112
pubmed: 35860735
Rheumatology (Oxford). 2022 Nov 28;61(12):4817-4826
pubmed: 35289842
Clin Exp Nephrol. 2013 Oct;17(5):603-606
pubmed: 24072416
J Clin Med. 2021 Apr 01;10(7):
pubmed: 33916214
J Clin Lab Anal. 2016 Sep;30(5):702-8
pubmed: 26987702
Ann Rheum Dis. 2001 Feb;60(2):170-2
pubmed: 11156552
Autoimmun Rev. 2022 Feb;21(2):102995
pubmed: 34798314
Transl Psychiatry. 2021 Sep 13;11(1):474
pubmed: 34518517
Hum Mol Genet. 2010 Mar 1;19(5):953-62
pubmed: 20007504
J Clin Immunol. 2008 Jul;28(4):285-90
pubmed: 18240009
Genes Immun. 2010 Jul;11(5):439-45
pubmed: 20508602
J Proteome Res. 2017 Jan 6;16(1):204-216
pubmed: 27700103
Mol Biol Cell. 2018 Jan 15;29(2):166-179
pubmed: 29167382
Nat Rev Mol Cell Biol. 2009 Oct;10(10):682-96
pubmed: 19773780
J Cell Biol. 2016 Oct 24;215(2):203-216
pubmed: 27810912
N Engl J Med. 2012 Jul 19;367(3):214-23
pubmed: 22808956
Nat Commun. 2018 Jul 13;9(1):2707
pubmed: 30006548
Arthritis Rheumatol. 2023 May;75(5):760-767
pubmed: 36409567
Medicine (Baltimore). 2018 Aug;97(34):e11727
pubmed: 30142759
Proteomics. 2008 Jul;8(14):2832-9
pubmed: 18655051
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2418-23
pubmed: 26884162
Nat Rev Rheumatol. 2016 Oct;12(10):570-9
pubmed: 27464484
Nephrol Dial Transplant. 2019 Feb 1;34(2):301-308
pubmed: 29718465
Arthritis Res Ther. 2017 Jun 7;19(1):129
pubmed: 28592297
Nat Rev Rheumatol. 2022 Jan;18(1):22-34
pubmed: 34853411
J Am Soc Nephrol. 2010 Dec;21(12):2169-79
pubmed: 20847144
Kidney Int. 2010 Sep;78(6):590-7
pubmed: 20592714
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8443-8
pubmed: 8710890
J Proteome Res. 2023 Apr 7;22(4):1105-1115
pubmed: 36475733
Ann Rheum Dis. 2009 Dec;68(12):1827-32
pubmed: 19054820
Nat Rev Rheumatol. 2017 Nov;13(11):683-692
pubmed: 28905856
Autoimmunity. 2019 Feb;52(1):1-11
pubmed: 30835561
J Neuropathol Exp Neurol. 2008 Jun;67(6):624-32
pubmed: 18520780
PLoS Genet. 2012;8(12):e1003140
pubmed: 23300462
FEBS J. 2022 Apr;289(8):2128-2144
pubmed: 34796656
BMC Biol. 2019 May 23;17(1):42
pubmed: 31122217
J Rheumatol. 2014 Jul;41(7):1366-73
pubmed: 24882836
J Clin Immunol. 2006 Sep;26(5):438-46
pubmed: 16941236

Auteurs

Federica Mescia (F)

Department of Medicine, University of Cambridge, Cambridge CB2 0SP, UK.
Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.
Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25121 Brescia, Italy.

Shaghayegh Bayati (S)

Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65 Stockholm, Sweden.

Elisabeth Brouwer (E)

Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.

Peter Heeringa (P)

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.

Erik J M Toonen (EJM)

R&D Department, Hycult Biotech, 5405 PB Uden, The Netherlands.

Marijke Beenes (M)

R&D Department, Hycult Biotech, 5405 PB Uden, The Netherlands.

Miriam J Ball (MJ)

Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.

Andrew J Rees (AJ)

Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.

Renate Kain (R)

Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.

Paul A Lyons (PA)

Department of Medicine, University of Cambridge, Cambridge CB2 0SP, UK.
Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.

Peter Nilsson (P)

Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65 Stockholm, Sweden.

Elisa Pin (E)

Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65 Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH